Head-to-head comparisons of medication uses, side effects, warnings, and more.
Yupelri (revefenacin)
Atrovent hfa (ipratropium)
Yupelri (revefenacin)
Atrovent hfa (ipratropium)
Summary of Yupelri vs. Atrovent HFA
Summary for LAMA
Prescription only
Yupelri (revefenacin) is an inhalation solution that's used to treat adults with chronic obstructive pulmonary disease (COPD). It belongs to the drug class called long-acting muscarinic antagonists, or LAMAs. Yupelri (revefenacin) is inhaled through the mouth once a day using a nebulizer machine. Some possible side effects include headache and cough. Yupelri (revefenacin) is a brand-name medication; there's currently no generic version available.
Summary for SAMA
Prescription only
Atrovent HFA (ipratropium) is a short-acting inhaled anticholinergic medication used to help with difficulty breathing in people with chronic obstructive pulmonary disease (COPD). This medication comes in an inhaler. Typically, you breathe in 2 inhalations, 4 times a day. You should use Atrovent HFA (ipratropium) regularly every day in order it for it to keep your COPD symptoms under control. It's not meant to be used as a rescue inhaler.